1/9
08:02 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
1/9
07:47 am
vor
Rating for VOR
Low
Report
Rating for VOR
1/9
07:47 am
vor
Rating for VOR
Low
Report
Rating for VOR
1/9
06:13 am
vor
Vor Bio initiated with a Buy at Citi
Low
Report
Vor Bio initiated with a Buy at Citi
12/19
11:23 am
vor
Rating for VOR
Medium
Report
Rating for VOR
12/9
08:07 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $43.00 price target on the stock.
Medium
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $43.00 price target on the stock.
12/9
07:07 am
vor
Rating for VOR
Medium
Report
Rating for VOR
12/9
04:59 am
vor
Vor Bio initiated with an Overweight at JPMorgan
High
Report
Vor Bio initiated with an Overweight at JPMorgan
11/25
09:06 am
vor
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
11/25
09:06 am
vor
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
11/25
09:04 am
vor
Rating for VOR
Medium
Report
Rating for VOR
11/25
09:04 am
vor
Rating for VOR
Medium
Report
Rating for VOR